Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trazodone for Sleep Quality in Chronic Orofacial Pain
NCT03522207Phase 4Terminated
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Oct 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trazodone in temporomandibular joint disorders (TMD), sponsored by Centre hospitalier de l’Université de Montréal. Started Oct 2018; status: terminated.
02
Drugs
trazodone
03
Conditions
temporomandibular joint disorders (TMD)
Beyond the preview
Go deeper on NCT03522207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03522207.